Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Advent Life Sciences on the deal. Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, made a lead...
You must be a Standard 1 Year member to access this content.
Bristows advised AviadoBio’s seed investors. AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused...
You must be a Standard 1 Year member to access this content.
Macfarlanes has advised Advent Life Sciences on the transaction. Advent Life Sciences raised two new life sciences-focused funds, Advent Life Sciences Fund III and the Advent-Harrington Impact...
You must be a Standard 1 Year member to access this content.
